London: An international team of scientists has announced a breakthrough in the fight against malaria, paving the way for the development of new drugs to treat the deadly disease.
According to the World Health Organisation malaria currently infects more than 225 million people worldwide and accounts for nearly 800,000 deaths per year.
Most deaths occur among children living in Africa where a child dies every 45 seconds of malaria and the disease accounts for approximately 20 per cent of all childhood deaths.
The disease is caused by the malaria parasite, Plasmodium that is injected into the human host through the bite of the female Anopheles mosquito.
Now researchers have discovered new ways in which the malarial parasite survives in the bloodstream of its victims, a release from the University of Leicester said.
The advance is the result of collaboration between medical scientists at the University of Leicester in the UK and a team from the French Institute National de la Sant et de
la Recherche Medicale (Inserm) working at the Welcome Trust Centre for Molecular Parasitology in Glasgow and the Ecole Polytechnique Federale de Lausanne (EPFL, Switzerland), now relocating to Monash University in Melbourne (Australia).
The breakthrough was made by the teams led by Professor Andrew Tobin at the University of Leicester and Professor Christian Doerig, now at Monash University, and is published in the prestigious scientific journal Nature Communications, the release said.
Professor Tobin, of the Department of Cell Physiology and Pharmacology, said: "I am proud to be involved in a collaboration that has made such an impact on malaria research. PTI PS "Our study opens new avenues for researchers to look for new drugs that treat malaria."
Professor Doerig explained: "We have shown that a crucial element that is required by malaria parasites to survive in the human blood stream is a group of enzymes called protein kinases.
If we stop these proteins kinases from working then we kill the malaria parasites.
We are now looking for drugs that do exactly that – stop the protein kinases from working.
If we find these drugs then we will have a new way of killing the malaria parasite."
Tobin added: "It seems perfectly realistic to us that we can now develop novel anti-malaria drugs based on the findings that we have made - it certainly is a big moment in our fight against this terrible disease that mainly affects the world`s poorest people."
However, the experts warned that the "parasite is very clever" at adapting to drug treatments and in so doing becoming resistant to drugs.
In fact, there is already evidence that the parasite is developing resistance to the most recent front line treatment for malaria, they said.
PTI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.